MSB 8.25% $1.05 mesoblast limited

aust. fourth largest biotech company

  1. 5,344 Posts.
    lightbulb Created with Sketch. 956
    With MSB,s Acquisition of U.S.A based Angioblast systems, makes MSB The world?s largest Stem cell company, and the fourth largest Australian biotech company, behind Majors CSL, Cochlear and ResMed. Its interesting to note the first mentioned two are at $32 and $69 respectively.(and incidently they retracted over the last five trading days. MSB advanced 2% over the same period)Then again they are making big profits our turn is coming. So my envision is to see MSB,s share price value to be sitting somewhere between the two majors within 5 years, and i believe that is being conserative .Cheers holders .... and we are growing .....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.05
Change
0.080(8.25%)
Mkt cap ! $1.196B
Open High Low Value Volume
99.5¢ $1.06 99.0¢ $4.636M 4.498M

Buyers (Bids)

No. Vol. Price($)
21 95109 $1.05
 

Sellers (Offers)

Price($) Vol. No.
$1.05 376066 28
View Market Depth
Last trade - 15.57pm 04/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.